A common polymorphism in the promoter region of the human AQP7 gene, resulting in AQP7 downregulation, is pathogenic for obesity and/or type 2 diabetes [142], while missense mutations in AQP7 are associated with an inability to increase the plasma glycerol during exercise [143]. Here, AQP7 is linked to obesity disorder.